MoneyWorks4Me

Celestial Biolabs informs about outcome of board meeting

14 Feb 2023 Evaluate
Celestial Biolabs has informed that the Board of Directors in their just concluded Board meeting held today have: Considered and adopted the Un-audited financial results of the Company for the quarter/ nine months ended 31.12.2022. In this connection attached the following: Copy of Un-audited financial results of the Company for the quarter / nine months ended 31.12.2022 along with Limited Review Report. The meeting commenced at 4.00 PM and ended at 4:30 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..